Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Australian Clinical Labs Ltd ( (AU:ACL) ) just unveiled an announcement.
Australian Clinical Labs Limited has announced the appointment of Ms. Sarah Butler and Mr. Grant Jeffery as non-executive directors, bringing extensive experience from diverse industries such as health, insurance, aerospace, and technology. Additionally, Mr. Matthew Cordingley will commence his role as the new Chief Financial Officer, starting 3 February 2025, which is expected to strengthen the company’s executive team and enhance its strategic positioning in the pathology services market.
More about Australian Clinical Labs Ltd
Australian Clinical Labs is a leading provider of pathology services across Australia, committed to excellence in medical testing and diagnostics. With state-of-the-art laboratories and a team of experienced professionals, ACL offers a comprehensive range of services to hospitals, medical specialists, and general practitioners.
YTD Price Performance: 6.40%
Average Trading Volume: 568,575
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$734.1M
For a thorough assessment of ACL stock, go to TipRanks’ Stock Analysis page.
